{"slideshow_credits": null, "snippet": "Novartis International agreed to buy Fougera Pharmaceuticals, a maker of generic skin care medicine, in a move that would make it the biggest manufacturer in the field.", "abstract": "Novartis International agreed to buy Fougera Pharmaceuticals, a maker of generic skin care medicine, in a move that would make it the biggest manufacturer in the field.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"lastname": "DE LA MERCED", "rank": 1, "firstname": "Michael", "role": "reported", "organization": "", "middlename": "J."}], "original": "By MICHAEL J. DE LA MERCED"}, "web_url": "http://dealbook.nytimes.com/2012/05/02/novartis-to-buy-fougera-pharmaceuticals-for-1-5-billion/", "lead_paragraph": null, "headline": {"main": "Novartis to Buy Fougera Pharmaceuticals for $1.5 Billion", "kicker": "dealbook"}, "_id": "4fd3a4488eb7c8105d8eeb3e", "word_count": "253", "multimedia": [], "pub_date": "2012-05-02T17:17:53Z", "source": "The New York Times", "news_desk": null, "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}